Clinical Trial Update: Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed disodium, gemcitabine, and bevacizumab in Stage IIIB/IV non-small cell lung cancer; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Gemcitabine (Gemcitabine)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-07-04